STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Get Free Report) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,400 shares, an increase of 26.3% from the April 30th total of 1,900 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 7,500 shares, the short-interest ratio is currently 0.3 days.
STRATA Skin Sciences Stock Performance
NASDAQ:SSKN opened at $2.33 on Thursday. The stock has a market cap of $9.72 million, a P/E ratio of -0.88 and a beta of 0.68. The stock has a 50 day simple moving average of $2.58 and a 200 day simple moving average of $2.77. The company has a current ratio of 1.13, a quick ratio of 0.94 and a debt-to-equity ratio of 1.62. STRATA Skin Sciences has a 1-year low of $2.10 and a 1-year high of $4.10.
STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) last released its quarterly earnings results on Wednesday, May 14th. The medical device company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($0.02). The firm had revenue of $6.81 million for the quarter, compared to analyst estimates of $7.28 million. STRATA Skin Sciences had a negative return on equity of 69.33% and a negative net margin of 28.72%. Research analysts anticipate that STRATA Skin Sciences will post -1.05 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on STRATA Skin Sciences
About STRATA Skin Sciences
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
See Also
- Five stocks we like better than STRATA Skin Sciences
- Which Wall Street Analysts are the Most Accurate?
- Intuit’s AI Boom: Stock Soaring, But Should Investors Hit Pause?
- How to Use the MarketBeat Excel Dividend Calculator
- Top Dividend Plays With Strong Analyst Ratings
- Insider Buying Explained: What Investors Need to Know
- Robinhood Stock Keeps Giving Investors Reasons To Buy
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.